State Street’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.2M | Buy |
3,565,992
+777,769
| +28% | +$12.4M | ﹤0.01% | 1723 |
|
|
2025
Q4 | $21.5M | Buy |
2,788,223
+1,781,904
| +177% | +$14.1M | ﹤0.01% | 2235 |
|
|
2025
Q3 | $7.42M | Buy |
1,006,319
+341,551
| +51% | +$1.75M | ﹤0.01% | 2804 |
|
|
2025
Q2 | $2.66M | Buy |
664,768
+434,730
| +189% | +$1.58M | ﹤0.01% | 3209 |
|
|
2025
Q1 | $732K | Buy |
230,038
+24,500
| +12% | +$115K | ﹤0.01% | 3503 |
|
|
2024
Q4 | $1.1M | Buy |
205,538
+27,292
| +15% | +$204K | ﹤0.01% | 3473 |
|
|
2024
Q3 | $941K | Buy |
178,246
+57,943
| +48% | +$208K | ﹤0.01% | 3497 |
|
|
2024
Q2 | $219K | Hold |
120,303
| – | – | ﹤0.01% | 3793 |
|
|
2024
Q1 | $214K | Sell |
120,303
-18,100
| -13% | -$37.8K | ﹤0.01% | 3860 |
|
|
2023
Q4 | $244K | Hold |
138,403
| – | – | ﹤0.01% | 3849 |
|
|
2023
Q3 | $202K | Hold |
138,403
| – | – | ﹤0.01% | 3939 |
|
|
2023
Q2 | $317K | Buy |
138,403
+25,800
| +23% | +$53.6K | ﹤0.01% | 3850 |
|
|
2023
Q1 | $102K | Hold |
112,603
| – | – | ﹤0.01% | 4318 |
|
|
2022
Q4 | $95.7K | Hold |
112,603
| – | – | ﹤0.01% | 4382 |
|
|
2022
Q3 | $92K | Hold |
112,603
| – | – | ﹤0.01% | 4490 |
|
|
2022
Q2 | $111K | Hold |
112,603
| – | – | ﹤0.01% | 4481 |
|
|
2022
Q1 | $185K | Buy |
112,603
+12,203
| +12% | +$22.3K | ﹤0.01% | 4408 |
|
|
2021
Q4 | $242K | Buy |
100,400
+34,000
| +51% | +$132K | ﹤0.01% | 4266 |
|
|
2021
Q3 | $321K | Buy |
66,400
+36,800
| +124% | +$109K | ﹤0.01% | 4158 |
|
|
2021
Q2 | $79K | Buy |
+29,600
| New | +$81.5K | ﹤0.01% | 4399 |
|
|
2019
Q4 | – | Sell |
-21,299
| Closed | -$64K | – | 3812 |
|
|
2019
Q3 | $64K | Buy |
21,299
+789
| +4% | +$3.31K | ﹤0.01% | 3704 |
|
|
2019
Q2 | $77K | Sell |
20,510
-191,807
| -90% | -$751K | ﹤0.01% | 3689 |
|
|
2019
Q1 | $854K | Buy |
212,317
+8,541
| +4% | +$36K | ﹤0.01% | 3361 |
|
|
2018
Q4 | $748K | Buy |
203,776
+20,552
| +11% | +$140K | ﹤0.01% | 3382 |
|
|
2018
Q3 | $1.57M | Buy |
183,224
+16,586
| +10% | +$166K | ﹤0.01% | 3328 |
|
|
2018
Q2 | $1.83M | Buy |
166,638
+70,159
| +73% | +$783K | ﹤0.01% | 3307 |
|
|
2018
Q1 | $1.11M | Sell |
96,479
-538
| -0.6% | -$5.09K | ﹤0.01% | 3326 |
|
|
2017
Q4 | $1M | Buy |
97,017
+27,664
| +40% | +$354K | ﹤0.01% | 3353 |
|
|
2017
Q3 | $1.1M | Buy |
69,353
+6,878
| +11% | +$95.2K | ﹤0.01% | 3360 |
|
|
2017
Q2 | $756K | Buy |
62,475
+9,779
| +19% | +$104K | ﹤0.01% | 3373 |
|
|
2017
Q1 | $1.09M | Buy |
52,696
+1,437
| +3% | +$22.5K | ﹤0.01% | 3239 |
|
|
2016
Q4 | $732K | Sell |
51,259
-2,849
| -5% | -$43.3K | ﹤0.01% | 3336 |
|
|
2016
Q3 | $890K | Buy |
54,108
+25,513
| +89% | +$368K | ﹤0.01% | 3214 |
|
|
2016
Q2 | $407K | Buy |
+28,595
| New | +$386K | ﹤0.01% | 3418 |
|
Other funds holding CRVS
O
ASP
VCM
VC
DTC
PA